Attachment 2 - Page 3 
9206 ^: 4 * 
y206-02S' 
9209-026 
9209-02r 
9209-028* 
9209-029 
9209-030 
9403-031/9209-031 
9209-032 
9209-033 
9212-034* 
9212 -035* 
(M) 
(M) 
(M) 
(M) 
(M) 
(M) 
(M) 
CD 
(M) 
CD 
CD 
CD 
Dunbar, Cynthia, National Institutes erf Health, Bethesda, Maryland; Renvviral-Mediaud Gene Transfer of Bone Marrow and j 
Peripheral Blood Stem Cells During Autologous Bone Marrow Transplantation for Metasumc Breast Cancer. 
RAC Approval: 6-2-92/NIH Approval: 8-14-92 | 
Minor Modification: 1-6-94 
Dunbar, Cynthia, National Institutes of Health, Bethesda, Maryland; Retroviral-Mediated Gene Transfer of Bone Marrow and 
Peripheral Blood Stem Cells During Autologous Bone Marrow Transplantation for Chronic Myelogenous Leukemia. I 
RAC Apprxjval: 6-2-92/NTH Approval: 8-14-92 ! 
Minor Modification: 1-6-94 
Minor Modification: 3-23-94 
Walker, Robert E., National Institutes of Health, Bethesda, Maryland; A Study of the Safety and Survival of the Adoptive Transfer of 
Genetically Marked Syngeneic Lymphocytes in fUV Ir\fecied Identical Twins. 
RAC Approval: 9-14-92/NlH Approval: 9-3-93 
Sebuening, Friedrich G,, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; A Phase l/II 
Study of PDCY321, a rhGM-CSF/rhIL-3 Fusion Protein or rhG-CSF.for the MobiUzation of Peripheral Blood Stem Cells for Autologous 
Stem Cell Transplantation. 
RAC Approval: 9-14-92/NIH Approval: 2-5-93 
Minor Modification: 2-25-94 
Schuening. Friedrich G,, Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; Evaluation of tl. 
Use of Recombinaru Human G-CSF Sdrnulated Peripheral Blood Progenitor Celt Supplementation in Autologous Bone Marrow 
Transplaruahon In Patients with Lymphoid Malignartciet. 
RAC Approval: 9-14-92/NTH Approval: 2t5-93 
Minor Mcxlification 2-25-94 
CLOSED; 2-25-94 (Merged with protocol / 9209-027) 
Schuening, Friedrich G^ Fred Hutchinson Cancer Research Center, University of Washington, Seattle, Washington; A Trial of G-CS 
Stimulated Peripheral Blood Stem Cells for Engraftmenl in Identical Twins. 
RAC Approval: 9-14-92/NIH ApprovaL 2-5-93 
CLOSED; Protocol Nerer Initiated 
Deisseroth, Albert B^ University of Texas MD Anderson Cancer Center, Houston, Texas; Use of Retroviral Markers to Identify 
Efficacy of Purging and Origin of Relapse Following Autologous Bone Marrow and Peripheral Blood Cell Trarxsplaruation in Indolent B 
Cell Seoplasms (Follicular Non-Hodgkin 't Lymphoma or Chronic Lymphocytic Leukemia) Patients. 
RAC Approval; 9-14-92/NIH Approval; 12-2-93 
Minor Modification; 11-3-93 | 
Minor Modifieatioo: 11-18-93 i 
I 
Roth, Jack A., The Unrversity of Texas MD Anderson Cancer Center. Houston. Texas: Clinical Protocol for Modification of \ 
Oncogene and Tumor Suppressor Gene Ejtpression in Non-Small Cell Lung Cancer NSCLC). ' 
9209-031/ RAC Approval of Original Protocol: 9-15-92/RAC AptJtoval of Oripnal Protocol Withdrawn 12-3-93 
9403-031/ RAC Aoproval of Resubmitted Protocol: 3-4-94 /NTH Approval of Resubmitted Protocol: Pending 
Brenner, Malcolm 1C, St Jude Qiildren't Research Hospital, Memphis, Tennessee; A Phase D Trial of the Baxter Neuroblastoma j 
Bone Marrow Purging System Using Gene Marking to Assets Efficacy. j 
RAC ApprovaL 9-15-92/NIH Approval: 2-5-93 I 
Lotze, Michael T. and Rubin, Joshua T^ University of Pittsburgh, Pittsburgh, Pennsylvania; Gene Therapy of Caruter: A Pilot Study j 
of lL-4 Gene Modified Antitumor Vaccines. \ 
RAC Approval; 9-15-92/NIH Approval: 2-5-93 
Crystal, Ronald G,, New York Hospital-Comell Medical Center, A Phase I Study, In Cystic Fibrosis Patients, of the Safety, Toxicity, i 
and Biological Efficacy of a Single Ad/rdnlstration of a Replication Deficient, Recombiruint Adenovirus Carrying the cDNA of the Norma 1 
Human Cytde Fibrosis Trar\smembrane Conductance Regulator Gene in the Lung. 
RAC ApprovaL 12-3-92/NIH ApprovaL 4-16-93 
Minor Modification: 5-17-93 
Minor Modiftcation; 10-8-93 
Minor ModifKation: 11-29-93 
Minor Modification: 2-4-94 
Wilson, James M,, Unrversity of Pennsylvania Medical Center, Philadelphia, Pennsylvania; Gene Therapy of Cystic Fibrosis Lung 
Diseases Using El Deleted Adenoviruses: A Phase I Trial. 
RAC ApprovaL 12-3-92/NIH ApprovaL 8-26-93 
Minor Modification: 8-17-93 
Minor Modificalioa* 8-26-93 
[3761 
Recombinant DNA Research, Volume 19 
